Based in New York City. Invests in Mobile Enterprise, Enterprise Software, Mobile, Big Data, Enterprise Security, SaaS, Mobile Commerce, CRM, B2B, Application Platforms, Cloud Data Services, Analytics, Crowdfunding, Early Stage IT, Biotechnology, Bioinformatics, Collaboration, Recruiting, Human Resources, Publishing, Small and Medium Businesses, ECommerce, Marketplaces
CEO @emerge_be a Brussels based investor with 30+ early-stage investments up to date in e-commerce tools, payments systems, telecom and space industries
Leveraging digital technology to make healthcare better, managing director @healthbox, angel investor, sports fanatic
Investor: @ginkgo, @rigetti, @notablelabs +16 more. Founder: @slidepay (exit ‘14). Operator: @google. Alum: @ycombinator, @terpswrestling #rwri. Seeking zeroes.
BioGenerator is an evergreen investor that creates, grows and invests in promising companies and entrepreneurs. The firm is the investment arm of BioSTL and it's work spans the early-stage startup lifecycle of companies within the health and plant sciences. The firm identifies and de-risks commercially promising innovations and services, advises innovators and entrepreneurs, recruits and supports entrepreneurial talent, makes staged investments grounded in rigorous due diligence and offers access to lab space and capital equipment..
Boehringer Ingelheim Venture Fund is the corporate venture capital arm of Boehringer Ingelheim. The firm invests in companies operating in the oncology, biologics, genetherapy, therapeutics and healthcare sectors. It is based in Ingelheim am Rhein, Germany and was founded in 2010.
Beta Fund is an early stage venture fund that focuses on emerging high tech and biotech. The firm invests early, typically at the angel financing stage, prior to typical venture capital financing, and in concert with other angel funds and groups.
BioAccel is a non-profit organization and an accelerator that provides funding and business expertise to develop early stage life science technologies that drive local economic development efforts. The firms invests in life sciences and research and technology companies focusing on biomedical, medical devices, tools, diagnostic platforms and service sectors. It is based in Phoenix, Arizona.
Founded in 1973, Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. The company invests across all stages of company development including early and late-stage venture financing, growth equity, and public companies. With offices in London, Boston and Menlo Park, Abingworth has backed more than 100 developing life science/medical businesses, over two-thirds of which have gone public, merged, or been acquired. Abingworth has funds under management of more than $1.25 billion. The firm has raised eleven funds since it was founded in 1973, the last nine of which have been entirely dedicated to life sciences and healthcare. Abingworth's investments are based in the U.S. and Europe including the U.K., Belgium, Denmark, France, Germany, Holland and Sweden. The firm's investments range from $20-80 million over more than one round of financing. In February 2014, the firm announced the final closing of its POUND 225M ($375M) fund, Abingworth Bioventures VI (ABV VI). ABV VI is Abingworth's 10th life sciences fund.
Bay City Capital is a private equity and venture capital firm that invests in the life sciences industry, with a focus on investing in companies within the bio-pharmaceuticals, drug discovery, medical devices, nutrition, healthcare IT and medical diagnostics sectors. The firm specializes in seed, early stage, mid and late-stage, PIPES, mezzanine, bridge and turnaround investments. It typically invests in North America with a focus on the Great Lakes and Mid-Atlantic region. It was founded in 1997 and is based in San Francisco, California.
Based in Bengaluru. Invests in Clean Technology, Consumer Internet, Enterprise Software, Mobile, Healthcare, Education, Edtech, Drones, Predictive Analytics, Analytics, Digital Media, Artificial Intelligence, Semiconductors, Biotechnology, Finance Technology, Agriculture
Social Impact Capital
Based in Silicon Valley. Invests in SaaS, Biotechnology, Synthetic Biology, Agriculture, Affordable Housing, Health and Wellness